AvPAK drugs
19 results
Amiodarone hydrochloride (amiodarone hydrochloride)
(Amiodarone Hydrochloride)AvPAK
Usage: Amiodarone hydrochloride tablets are indicated for treating life-threatening recurrent ventricular fibrillation and hemodynamically unstable tachycardia in adults unresponsive to other antiarrhythmics or when alternatives are intolerable.
Atomoxetine hydrochloride (atomoxetine hydrochloride)
(atomoxetine hydrochloride)AvPAK
Usage: Atomoxetine is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in both pediatric and adult patients. It is part of a comprehensive treatment program, which may include psychological, educational, and social interventions. Drug treatment is not intended for symptoms solely due to environmental factors or other psychiatric disorders.
Atovaquone (atovaquone)
(Atovaquone)AvPAK
Usage: Atovaquone oral suspension is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents aged 13 years and older who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Its use is limited to mild-to-moderate cases.
Bupropion hydrochloride (bupropion hydrochloride)
(Bupropion Hydrochloride)AvPAK
Usage: Bupropion hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder (MDD) and the prevention of seasonal major depressive episodes in seasonal affective disorder (SAD). Efficacy is supported by multiple controlled trials for both conditions.
Cinacalcet (cinacalcet)
(Cinacalcet)AvPAK
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in patients with parathyroid carcinoma, and hypercalcemia in adults with primary hyperparathyroidism who cannot undergo parathyroidectomy. It is not recommended for patients with CKD not on dialysis due to hypocalcemia risk.
Doxazosin (doxazosin)
(Doxazosin)AvPAK
Usage: Doxazosin tablets are indicated for treating the signs and symptoms of benign prostatic hyperplasia (BPH) and for lowering blood pressure in patients with hypertension, thereby reducing the risk of cardiovascular events, including strokes and myocardial infarctions. It may be used alone or with other antihypertensive medications.
Duloxetine (duloxetine)
(Duloxetine)AvPAK
Usage: Duloxetine delayed-release capsules are indicated for treating major depressive disorder, generalized anxiety disorder in adults and pediatric patients (7+ years), diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain in adults. Pediatric usage information exists but is not included on the label due to exclusivity rights.
Entacapone (entacapone)
(Entacapone)AvPAK
Usage: Entacapone tablets are indicated as an adjunct therapy to levodopa and carbidopa for treating end-of-dose "wearing-off" in Parkinson’s disease patients. Its effectiveness has not been evaluated in those without this specific symptom.
Hydroxychloroquine sulfate (hydroxychloroquine sulfate)
(HYDROXYCHLOROQUINE SULFATE)AvPAK
Usage: Hydroxychloroquine Sulfate Tablets are indicated for the treatment of uncomplicated malaria, including infections due to *P. falciparum, P. malariae, P. ovale,* and *P. vivax.* They also serve as prophylaxis in areas without chloroquine resistance. Additionally, they are used for chronic discoid lupus erythematosus and rheumatoid arthritis.
Levetiracetam (levetiracetam)
(Levetiracetam)AvPAK
Usage: Levetiracetam oral solution is indicated as adjunctive therapy for treating partial onset seizures in patients 1 month and older, myoclonic seizures in patients 12 years and older with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients 6 years and older with idiopathic generalized epilepsy.